Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Peripheral Artery Disease Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

100 recruiting trials for Peripheral Artery Disease. Eligibility criteria explained in plain English.

TrialFinderData lists 100 Peripheral Artery Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 3 is the largest group at 29% (5 studies); the largest phase groups are Phase 3: 5, Phase 4: 4, Phase 2: 4, Phase 1 / Phase 2: 2.

Research is led by VA Office of Research and Development (6), University of Nebraska (4), Acotec Scientific Co., Ltd (3), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo (drug, 5 trials), followed by Rivaroxaban, Exercise.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Track Peripheral Artery Disease trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06330493

AcoArt Litos PCB Below-the-knee Global Trial

The objective of this study is to assess whether efficacy of the AcoArt Litos PCB is superior and whether safety of AcoArt Litos PCB is noninferior to the control device (FDA...

Sponsor: Acotec Scientific Co., LtdEnrolling: 28819 locations
RECRUITINGNCT07614386

Radial Access Data in Vascular Interventions Registry

The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The...

Sponsor: Mersin Medicalpark HastanesiEnrolling: 200001 location
RECRUITINGNCT06296576

Acceleration Time Assessment for Prediction of Critical Limb Ischemia

Critical Limb Ischaemia (CLI), the final stage of arterial disease, is a therapeutic emergency whose prognosis depends largely on the time taken to diagnose it. The growing...

Sponsor: Centre Hospitalier le MansEnrolling: 4313 locations
RECRUITINGNCT07144150

EVERO Drug-coated Balloon (DCB) Randomized Trial

The primary objective of the study is to evaluate the long-term safety and effectiveness of the Advance Evero™ 18 Everolimus-coated Percutaneous Transluminal Angioplasty Balloon...

Sponsor: Cook Research IncorporatedEnrolling: 4104 locations
RECRUITINGNCT07383220

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

The goal of this clinical trial is to learn if the combination between transcutaneous electrical nerve stimulation (TENS) and isometric exercise (IE) can improve blood pressure in...

Sponsor: Mohamed Mohamed Ali MorganEnrolling: 501 location
RECRUITINGNCT07016698

Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)

The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.

Sponsor: C. R. BardEnrolling: 6002 locations
RECRUITINGPhase 3NCT07318610

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

This study is researching 2 different experimental drugs called REGN7508 and REGN9933. The study is focused on people who have Peripheral Artery Disease (PAD), which means that...

Sponsor: Regeneron PharmaceuticalsEnrolling: 70504 locations
RECRUITINGNCT07173062

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

The Western diet, rich in fat and sugar, contributes to cardiovascular risk and alters the body metabolism, specifically through the modulation of the microbiome. Microbiome is...

Sponsor: Universidade do PortoEnrolling: 1501 location
RECRUITINGNCT06082466

FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial

The purpose of this clinical trial is to analyze patency after autologous infrainguinal bypass surgery in patients receiving a venous conduit versus a covered venous conduit.

Sponsor: Paracelsus Medical UniversityEnrolling: 1101 location
RECRUITINGNCT06067789

The ALOFT Pilot Trial

The ALOFT Pilot Trial will evaluate three pragmatic elements (recruitment, adherence, and follow-up) of neuraxial versus general anesthesia for lower limb revascularization...

Sponsor: Ottawa Hospital Research InstituteEnrolling: 901 location
RECRUITINGNCT06149650

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to...

Sponsor: Cardiovascular and Interventional Radiological Society of EuropeEnrolling: 40020 locations
RECRUITINGNCT04228978

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline...

Sponsor: Northwestern UniversityEnrolling: 2127 locations
RECRUITINGNCT07613840

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

The goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery...

Sponsor: Massachusetts General HospitalEnrolling: 4842 locations
RECRUITINGNCT02748226

Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb...

1. Study design: multicenter retrospective and prospective observational study 2. Study Cohort : 1. Retrospective cohort: This cohort retrospectively enrolls patients with...

Sponsor: Yonsei UniversityEnrolling: 120001 location
RECRUITINGNCT06516315

Feasibility Study of an Angiographic Quantitative Flow Ratio-guided Endovascular Procedure in Patients With Lower Limbs...

The main objective of this study is to explore the feasibility of using the angiographic Quantitative Flow Ratio (QFR) as a tool to predict the success rate of endovascular...

Sponsor: Fondation Hôpital Saint-JosephEnrolling: 351 location
RECRUITINGNCT06952543

Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease

The purpose of this study is to develop a new noninvasive tool for early diagnosis of Peripheral Arterial Disease (PAD) and use the proposed method for monitoring the disease...

Sponsor: Mayo ClinicEnrolling: 4001 location
RECRUITINGPhase 4NCT05854615

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysian patients with...

Sponsor: Cell Biopeutics Resources Sdn BhdEnrolling: 31 location
RECRUITINGPhase 4NCT02842424

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Peripheral artery disease (PAD) is a manifestation of atherosclerosis that produces progressive narrowing and occlusion of the arteries supplying the lower extremities. The most...

Sponsor: University of NebraskaEnrolling: 701 location
RECRUITINGPhase 3NCT04433572

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major...

Sponsor: Mercator MedSystems, Inc.Enrolling: 2502 locations
RECRUITINGNCT07122167

Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for...

This is a prospective, multi-center, single-arm post-market study evaluating the safety and effectiveness of the ZENFLEX Pro™ Drug-eluting Stent in treating femoropopliteal artery...

Sponsor: MDCECRO LLCEnrolling: 1531 location
RECRUITINGNCT06742801

Onyx™ Liquid Embolic IDE Clinical Study

The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside...

Sponsor: Medtronic EndovascularEnrolling: 11918 locations
RECRUITINGPhase 3NCT04774159

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine...

Sponsor: Population Health Research InstituteEnrolling: 615020 locations
RECRUITINGNCT03594344

Additional Hyperbaric Oxygen After Lower Extremity Amputation

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment...

Sponsor: Oslo University HospitalEnrolling: 1202 locations
RECRUITINGNCT05551780

Treatment of Calcific Total Occlusions in Peripheral Artery Disease

Prospective, multi-center, non-randomized, open label, clinical study intended to provide data to demonstrate safety and performance of the SoundBite Crossing System XS Peripheral.

Sponsor: SoundBite Medical Solutions, Inc.Enrolling: 1305 locations
RECRUITINGPhase 2NCT06482892

TP03HN106 in Patients With Critical Limb Ischemia

Critical limb ischemia (CLI) is the most severe ischemic stage in peripheral arterial disease (PAD) of the lower limbs, characterized by decreased walking ability, resting pain...

Sponsor: Talengen Institute of Life Sciences, Shenzhen, P.R. China.Enrolling: 151 location
RECRUITINGNCT06409949

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology

In our research, we are delving into whether taking MitoQ for six months can improve the symptoms and function of people diagnosed with peripheral artery disease, especially those...

Sponsor: University of NebraskaEnrolling: 601 location
RECRUITINGNCT07226193

Detecting Peripheral Artery Disease With the Pulse

1\) The purpose of this study is to assess segmental pulse arrival time (PAT) as an alternative biomarker to detect lower-extremity peripheral artery disease (PAD), and to...

Sponsor: University of NebraskaEnrolling: 601 location
RECRUITINGNCT06066268

miRNAs in Critical Limb Ischemia (miRNACLI)

For the present study, 40 patients affected by critical limb ischemia of different severity will be enrolled: patients affected by critical limb ischemia undergoing subgenual...

Sponsor: IRCCS Policlinico S. DonatoEnrolling: 801 location
RECRUITINGPhase 4NCT06777901

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it...

Sponsor: Angiodynamics, Inc.Enrolling: 2249 locations
RECRUITINGNCT07609095

Peripheral pULSe Assessment and Arterial pRessure (PULSAR)

This prospective multicenter observational study aims to investigate the relationship between palpable peripheral pulses and simultaneously measured arterial blood pressure in...

Sponsor: Region StockholmEnrolling: 50001 location
RECRUITINGNCT06274697

Validation of a Magnetic Sensor in Arterial Flow Recording, Compared With the Reference Method, at Various Peripheral...

The measurement of magnetic fields emitted by cardiac activity has already been studied in magneto-cardiography. To date, however, this technology has never been evaluated in the...

Sponsor: University Hospital, MontpellierEnrolling: 701 location
RECRUITINGNCT06782100

MRI Guided Management of Occlusive Peripheral Arterial Disease

The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize...

Sponsor: The Methodist Hospital Research InstituteEnrolling: 1751 location
RECRUITINGNCT04793581

Assessment of the Utility of the Pantheris Small Vessel (SV) System

A single-arm study to assess the utility of the Pantheris SV catheter in addressing peripheral artery disease in arteries located below the knee. Data will be collected on the...

Sponsor: Avinger, Inc.Enrolling: 602 locations
RECRUITINGNCT05134311

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies

The ability to have a visual aid to depict areas of vascular disease that are affecting the patient's health can help in patient comprehension of the problem. This comprehension...

Sponsor: Northwell HealthEnrolling: 2701 location
RECRUITINGNCT06071429

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

The objective of this prospective, single-blinded, randomized controlled trial is to evaluate the safety and efficacy of the MAGNITUDE BRS System for the planned treatment of...

Sponsor: R3 Vascular Inc.Enrolling: 3003 locations
RECRUITINGNCT06228677

Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

To explore the relationship between perioperative blood pressure and catecholamine concentrations in adrenal venous blood and peripheral venous blood in hypertensive patients with...

Sponsor: First Affiliated Hospital of Chengdu Medical CollegeEnrolling: 1961 location
RECRUITINGNCT06626646

Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)

PAD-VRCE is an observational, cross-sectional, two arm study aimed at determining if the presence of peripheral artery disease (PAD) can influence the number of circulating...

Sponsor: Canadian Medical and Surgical Knowledge Translation Research GroupEnrolling: 402 locations
RECRUITINGNCT06033924

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study...

Sponsor: VA Office of Research and DevelopmentEnrolling: 2253 locations
RECRUITINGNCT04889105

Exercise Therapy for PAD Using Mobile Health

Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans...

Sponsor: VA Office of Research and DevelopmentEnrolling: 751 location
RECRUITINGNCT07374601

The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease

Peripheral artery disease (PAD) is a chronic atherosclerotic disorder characterized by stenosis or occlusion of the extracranial arteries distal to the aortic arch, most commonly...

Sponsor: Peking University First HospitalEnrolling: 3001 location
RECRUITINGNCT07330635

Chronic Wounds and Blood Circulation Detection

Lower limb circulatory insufficiency and the associated chronic wounds are common health problems among the elderly. These issues not only affect the individual's mobility and...

Sponsor: National Health Research Institutes, TaiwanEnrolling: 4251 location
RECRUITINGNCT06951685

Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study

A prospective, single arm, non-randomized early feasibility study to evaluate the preliminary safety and performance of the XPAD conduit in patients with peripheral arterial...

Sponsor: XeltisEnrolling: 61 location
RECRUITINGNCT06631378

Transverse Versus Longitudinal Groin Incision in Vascular Surgery

The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery....

Sponsor: Kolding SygehusEnrolling: 2321 location
RECRUITINGNCT06075940

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee...

The objective of this prospective, multi-center, clinical investigation is to evaluate the MAGNITUDE BRS System for the planned treatment of narrowed infrapopliteal lesions. Up to...

Sponsor: R3 Vascular Inc.Enrolling: 301 location
RECRUITINGNCT05884840

New Cardiovascular Risk Screening Strategy.

Mortality due to cardiovascular disease (CVD) in Spain accounted for 29% of all deaths (32% in women and 26% in men) in 2017. Out of those, 67% were related to a coronary or a...

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaEnrolling: 540001 location
RECRUITINGNCT07497360

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

Peripheral artery disease (PAD) is a chronic and progressive condition caused by narrowing or blockage of arteries in the lower limbs due to atherosclerosis. It primarily affects...

Sponsor: Izmir Democracy UniversityEnrolling: 451 location
RECRUITINGNCT06573437

Clinical Performance of the VESTO® Vascular Stent for Treatment of Iliac Peripheral Obstructive Arterial Disease

This study will validate the efficacy and safety of the VESTO® Vascular Stent for treating patients with iliac peripheral arterial obstructive disease in a post-market clinical...

Sponsor: Braile Biomedica Ind. Com. e Repr. Ltda.Enrolling: 1006 locations
RECRUITINGNCT06838572

Effect of Remote Local Peripheral Nerve Cooling on Pain of Arterial Puncture

In this project, volunteers will be recruited to cool the superficial skin of the axillary brachial plexus away from the puncture point, resulting in local peripheral nerve...

Sponsor: The Second Affiliated Hospital of Chongqing Medical UniversityEnrolling: 1001 location
RECRUITINGNCT07012070

Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers

Peripheral Arterial Disease (PAD) of the lower extremities is common and prevalence of PAD is increasing in our aging population. The presence of PAD is associated with increased...

Sponsor: Chinese University of Hong KongEnrolling: 702 locations
RECRUITINGPhase 4NCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood...

Sponsor: VA Office of Research and DevelopmentEnrolling: 741020 locations

Showing 50 of 100 trials.Search all Peripheral Artery Disease trials

Frequently Asked Questions

There are currently 100 clinical trials for Peripheral Artery Disease, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Peripheral Artery Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 5 Phase 3 trials for Peripheral Artery Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.